Zika Virus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
Condition:   Zika Virus Interventions:   Biological: mRNA-1893;   Other: Placebo Sponsors:   ModernaTX, Inc.;   Biomedical Advanced Research and Development Authority Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2019 Category: Research Source Type: clinical trials